Abstract
OBJECTIVE: The purpose of this report is to describe a 57-year-old man who was admitted to a nursing facility for physical therapy. His home medication list included sodium oxybate. This article will provide the pharmacist with a therapeutic overview of sodium oxybate as well as review the unique processes involved with drug acquisition, dosing, patient education, and monitoring. SETTING: Community pharmacy, nursing facility pharmacy, consultant pharmacy practice. PRACTICE CONSIDERATIONS: Sodium oxybate is the only medication in the United States that has approval for both treatment of cataplexy in narcolepsy and treatment of excessive daytime sleepiness in narcolepsy. Sodium oxybate has many unique properties that cause it to differ from past therapies for cataplexy and excessive daytime sleepiness associated with narcolepsy. CONCLUSION: It is important for pharmacists to understand the therapeutic uses of sodium oxybate and to review the processes for acquisition, dosing, and administration to better assist physicians and patients and improve therapeutic outcomes.
| Original language | English |
|---|---|
| Pages (from-to) | 547-554 |
| Number of pages | 8 |
| Journal | Consultant Pharmacist |
| Volume | 29 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 1 2014 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmacology (medical)
Cite this
Sodium oxybate : A primer for pharmacists in the treatment off narcolepsy. / Castillo, Shana; Begley, Kimberley J.; Malesker, Mark A.; Steinshouer, Chloe.
In: Consultant Pharmacist, Vol. 29, No. 8, 01.08.2014, p. 547-554.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Sodium oxybate
T2 - A primer for pharmacists in the treatment off narcolepsy
AU - Castillo, Shana
AU - Begley, Kimberley J.
AU - Malesker, Mark A.
AU - Steinshouer, Chloe
PY - 2014/8/1
Y1 - 2014/8/1
N2 - OBJECTIVE: The purpose of this report is to describe a 57-year-old man who was admitted to a nursing facility for physical therapy. His home medication list included sodium oxybate. This article will provide the pharmacist with a therapeutic overview of sodium oxybate as well as review the unique processes involved with drug acquisition, dosing, patient education, and monitoring. SETTING: Community pharmacy, nursing facility pharmacy, consultant pharmacy practice. PRACTICE CONSIDERATIONS: Sodium oxybate is the only medication in the United States that has approval for both treatment of cataplexy in narcolepsy and treatment of excessive daytime sleepiness in narcolepsy. Sodium oxybate has many unique properties that cause it to differ from past therapies for cataplexy and excessive daytime sleepiness associated with narcolepsy. CONCLUSION: It is important for pharmacists to understand the therapeutic uses of sodium oxybate and to review the processes for acquisition, dosing, and administration to better assist physicians and patients and improve therapeutic outcomes.
AB - OBJECTIVE: The purpose of this report is to describe a 57-year-old man who was admitted to a nursing facility for physical therapy. His home medication list included sodium oxybate. This article will provide the pharmacist with a therapeutic overview of sodium oxybate as well as review the unique processes involved with drug acquisition, dosing, patient education, and monitoring. SETTING: Community pharmacy, nursing facility pharmacy, consultant pharmacy practice. PRACTICE CONSIDERATIONS: Sodium oxybate is the only medication in the United States that has approval for both treatment of cataplexy in narcolepsy and treatment of excessive daytime sleepiness in narcolepsy. Sodium oxybate has many unique properties that cause it to differ from past therapies for cataplexy and excessive daytime sleepiness associated with narcolepsy. CONCLUSION: It is important for pharmacists to understand the therapeutic uses of sodium oxybate and to review the processes for acquisition, dosing, and administration to better assist physicians and patients and improve therapeutic outcomes.
UR - http://www.scopus.com/inward/record.url?scp=84928334995&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84928334995&partnerID=8YFLogxK
U2 - 10.4140/TCP.n.2014.547
DO - 10.4140/TCP.n.2014.547
M3 - Article
C2 - 25203262
AN - SCOPUS:84928334995
VL - 29
SP - 547
EP - 554
JO - The Senior care pharmacist
JF - The Senior care pharmacist
SN - 2639-9636
IS - 8
ER -